nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—Platinum-containing Compounds—Carboplatin—esophageal cancer	0.4	1	CiPCiCtD
Cisplatin—lung cancer—esophageal cancer	0.162	1	CtDrD
Cisplatin—GSTT1—esophageal cancer	0.0658	0.49	CbGaD
Cisplatin—ABCC2—esophageal cancer	0.038	0.283	CbGaD
Cisplatin—SLC31A2—Carboplatin—esophageal cancer	0.0325	0.139	CbGbCtD
Cisplatin—MT2A—Carboplatin—esophageal cancer	0.0235	0.1	CbGbCtD
Cisplatin—MT1A—Carboplatin—esophageal cancer	0.0235	0.1	CbGbCtD
Cisplatin—ATP7B—Carboplatin—esophageal cancer	0.0235	0.1	CbGbCtD
Cisplatin—ATP7A—Carboplatin—esophageal cancer	0.0235	0.1	CbGbCtD
Cisplatin—SLC31A1—Carboplatin—esophageal cancer	0.0187	0.0797	CbGbCtD
Cisplatin—SOD1—Carboplatin—esophageal cancer	0.0187	0.0797	CbGbCtD
Cisplatin—PTGS2—esophageal cancer	0.0165	0.123	CbGaD
Cisplatin—GSTT1—Carboplatin—esophageal cancer	0.0156	0.0667	CbGbCtD
Cisplatin—ABCB1—esophageal cancer	0.014	0.104	CbGaD
Cisplatin—GSTM1—Carboplatin—esophageal cancer	0.0135	0.0576	CbGbCtD
Cisplatin—NQO1—Carboplatin—esophageal cancer	0.0107	0.0458	CbGbCtD
Cisplatin—GSTP1—Carboplatin—esophageal cancer	0.00976	0.0416	CbGbCtD
Cisplatin—XDH—Carboplatin—esophageal cancer	0.00561	0.0239	CbGbCtD
Cisplatin—MPO—Carboplatin—esophageal cancer	0.00561	0.0239	CbGbCtD
Cisplatin—ABCC3—Methotrexate—esophageal cancer	0.00239	0.0102	CbGbCtD
Cisplatin—ABCC2—Carboplatin—esophageal cancer	0.00196	0.00836	CbGbCtD
Cisplatin—ABCG2—Carboplatin—esophageal cancer	0.00177	0.00756	CbGbCtD
Cisplatin—CYP2C9—Capecitabine—esophageal cancer	0.00112	0.00476	CbGbCtD
Cisplatin—ABCC2—Methotrexate—esophageal cancer	0.00109	0.00464	CbGbCtD
Cisplatin—BCHE—diaphragm—esophageal cancer	0.00106	0.0625	CbGeAlD
Cisplatin—ABCG2—Methotrexate—esophageal cancer	0.000983	0.00419	CbGbCtD
Cisplatin—SLC31A2—exocrine gland—esophageal cancer	0.000834	0.0492	CbGeAlD
Cisplatin—Venous thrombosis—Carboplatin—esophageal cancer	0.000815	0.0558	CcSEcCtD
Cisplatin—Spinal cord disorder—Methotrexate—esophageal cancer	0.000751	0.0514	CcSEcCtD
Cisplatin—Leukoencephalopathy—Methotrexate—esophageal cancer	0.000751	0.0514	CcSEcCtD
Cisplatin—Fluid overload—Carboplatin—esophageal cancer	0.000708	0.0484	CcSEcCtD
Cisplatin—GSTT1—neck—esophageal cancer	0.000531	0.0313	CbGeAlD
Cisplatin—Extravasation—Carboplatin—esophageal cancer	0.000504	0.0345	CcSEcCtD
Cisplatin—Urine output—Methotrexate—esophageal cancer	0.000408	0.0279	CcSEcCtD
Cisplatin—GSTM1—neck—esophageal cancer	0.000391	0.0231	CbGeAlD
Cisplatin—GSTP1—exocrine gland—esophageal cancer	0.000383	0.0226	CbGeAlD
Cisplatin—Phlebitis—Carboplatin—esophageal cancer	0.000371	0.0254	CcSEcCtD
Cisplatin—Gastrointestinal ulcer haemorrhage—Methotrexate—esophageal cancer	0.000369	0.0253	CcSEcCtD
Cisplatin—SLC31A2—bronchus—esophageal cancer	0.000357	0.0211	CbGeAlD
Cisplatin—ABCB1—Methotrexate—esophageal cancer	0.000354	0.00151	CbGbCtD
Cisplatin—ATP7B—trachea—esophageal cancer	0.000351	0.0207	CbGeAlD
Cisplatin—MT1A—digestive system—esophageal cancer	0.000337	0.0199	CbGeAlD
Cisplatin—Fibrosis—Capecitabine—esophageal cancer	0.000333	0.0228	CcSEcCtD
Cisplatin—SLC31A2—trachea—esophageal cancer	0.000321	0.0189	CbGeAlD
Cisplatin—ATP7A—epithelium—esophageal cancer	0.00032	0.0189	CbGeAlD
Cisplatin—ATP7A—bronchus—esophageal cancer	0.000315	0.0186	CbGeAlD
Cisplatin—Pulmonary toxicity—Methotrexate—esophageal cancer	0.000312	0.0213	CcSEcCtD
Cisplatin—CYP4A11—digestive system—esophageal cancer	0.000311	0.0183	CbGeAlD
Cisplatin—ATP7A—trachea—esophageal cancer	0.000283	0.0167	CbGeAlD
Cisplatin—MT1A—lung—esophageal cancer	0.000282	0.0166	CbGeAlD
Cisplatin—MT2A—digestive system—esophageal cancer	0.000281	0.0166	CbGeAlD
Cisplatin—SOD1—bronchus—esophageal cancer	0.000276	0.0163	CbGeAlD
Cisplatin—GSTT1—digestive system—esophageal cancer	0.000275	0.0162	CbGeAlD
Cisplatin—NQO1—neck—esophageal cancer	0.000274	0.0162	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—esophageal cancer	0.00027	0.0159	CbGeAlD
Cisplatin—SLC31A1—bronchus—esophageal cancer	0.000269	0.0159	CbGeAlD
Cisplatin—Azoospermia—Methotrexate—esophageal cancer	0.000263	0.018	CcSEcCtD
Cisplatin—ATP7B—lung—esophageal cancer	0.000252	0.0149	CbGeAlD
Cisplatin—Fibrosis—Methotrexate—esophageal cancer	0.000248	0.017	CcSEcCtD
Cisplatin—SOD1—trachea—esophageal cancer	0.000247	0.0146	CbGeAlD
Cisplatin—Neurotoxicity—Capecitabine—esophageal cancer	0.000245	0.0168	CcSEcCtD
Cisplatin—GSTP1—neck—esophageal cancer	0.000245	0.0145	CbGeAlD
Cisplatin—SLC31A1—trachea—esophageal cancer	0.000241	0.0142	CbGeAlD
Cisplatin—MT2A—lung—esophageal cancer	0.000235	0.0138	CbGeAlD
Cisplatin—SLC31A2—lung—esophageal cancer	0.000231	0.0136	CbGeAlD
Cisplatin—GSTT1—lung—esophageal cancer	0.00023	0.0136	CbGeAlD
Cisplatin—SLC31A1—digestive system—esophageal cancer	0.000207	0.0122	CbGeAlD
Cisplatin—XDH—digestive system—esophageal cancer	0.000205	0.0121	CbGeAlD
Cisplatin—ATP7A—lung—esophageal cancer	0.000203	0.012	CbGeAlD
Cisplatin—Skin necrosis—Methotrexate—esophageal cancer	0.000203	0.0139	CcSEcCtD
Cisplatin—GSTM1—digestive system—esophageal cancer	0.000202	0.012	CbGeAlD
Cisplatin—ABCC5—bronchus—esophageal cancer	0.000196	0.0116	CbGeAlD
Cisplatin—MT1A—lymph node—esophageal cancer	0.000193	0.0114	CbGeAlD
Cisplatin—NQO1—epithelium—esophageal cancer	0.000187	0.011	CbGeAlD
Cisplatin—ABCC6—lung—esophageal cancer	0.000186	0.011	CbGeAlD
Cisplatin—NQO1—bronchus—esophageal cancer	0.000184	0.0108	CbGeAlD
Cisplatin—Neurotoxicity—Methotrexate—esophageal cancer	0.000183	0.0125	CcSEcCtD
Cisplatin—NQO1—smooth muscle tissue—esophageal cancer	0.00018	0.0106	CbGeAlD
Cisplatin—SOD1—lung—esophageal cancer	0.000178	0.0105	CbGeAlD
Cisplatin—Venous thrombosis—Capecitabine—esophageal cancer	0.000176	0.0121	CcSEcCtD
Cisplatin—SLC31A1—lung—esophageal cancer	0.000173	0.0102	CbGeAlD
Cisplatin—ATP7B—lymph node—esophageal cancer	0.000173	0.0102	CbGeAlD
Cisplatin—MPO—epithelium—esophageal cancer	0.000172	0.0101	CbGeAlD
Cisplatin—GSTM1—lung—esophageal cancer	0.000169	0.00998	CbGeAlD
Cisplatin—GSTP1—epithelium—esophageal cancer	0.000167	0.00984	CbGeAlD
Cisplatin—NQO1—trachea—esophageal cancer	0.000165	0.00974	CbGeAlD
Cisplatin—GSTP1—bronchus—esophageal cancer	0.000164	0.00969	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—esophageal cancer	0.000161	0.00948	CbGeAlD
Cisplatin—SLC22A2—digestive system—esophageal cancer	0.000161	0.00948	CbGeAlD
Cisplatin—Febrile neutropenia—Capecitabine—esophageal cancer	0.000158	0.0108	CcSEcCtD
Cisplatin—SLC31A2—lymph node—esophageal cancer	0.000158	0.00931	CbGeAlD
Cisplatin—Infection—Carboplatin—esophageal cancer	0.000156	0.0107	CcSEcCtD
Cisplatin—Serum creatinine increased—Capecitabine—esophageal cancer	0.000155	0.0106	CcSEcCtD
Cisplatin—GSTP1—trachea—esophageal cancer	0.000147	0.0087	CbGeAlD
Cisplatin—NQO1—digestive system—esophageal cancer	0.000142	0.00838	CbGeAlD
Cisplatin—ATP7A—lymph node—esophageal cancer	0.000139	0.0082	CbGeAlD
Cisplatin—Pain—Carboplatin—esophageal cancer	0.000134	0.00919	CcSEcCtD
Cisplatin—MPO—digestive system—esophageal cancer	0.00013	0.0077	CbGeAlD
Cisplatin—ABCC3—digestive system—esophageal cancer	0.000127	0.00752	CbGeAlD
Cisplatin—GSTP1—digestive system—esophageal cancer	0.000127	0.00749	CbGeAlD
Cisplatin—ABCC5—lung—esophageal cancer	0.000127	0.00748	CbGeAlD
Cisplatin—Body temperature increased—Carboplatin—esophageal cancer	0.000124	0.00849	CcSEcCtD
Cisplatin—Hepatotoxicity—Capecitabine—esophageal cancer	0.000123	0.00843	CcSEcCtD
Cisplatin—SOD1—lymph node—esophageal cancer	0.000122	0.00718	CbGeAlD
Cisplatin—NQO1—lung—esophageal cancer	0.000119	0.007	CbGeAlD
Cisplatin—SLC31A1—lymph node—esophageal cancer	0.000119	0.007	CbGeAlD
Cisplatin—Febrile neutropenia—Methotrexate—esophageal cancer	0.000118	0.00806	CcSEcCtD
Cisplatin—Rhinorrhoea—Capecitabine—esophageal cancer	0.000117	0.00804	CcSEcCtD
Cisplatin—Ageusia—Capecitabine—esophageal cancer	0.000117	0.00804	CcSEcCtD
Cisplatin—GSTM1—lymph node—esophageal cancer	0.000116	0.00683	CbGeAlD
Cisplatin—MPO—lung—esophageal cancer	0.000109	0.00643	CbGeAlD
Cisplatin—ABCC3—lung—esophageal cancer	0.000106	0.00628	CbGeAlD
Cisplatin—GSTP1—lung—esophageal cancer	0.000106	0.00625	CbGeAlD
Cisplatin—Cellulitis—Capecitabine—esophageal cancer	0.000105	0.00716	CcSEcCtD
Cisplatin—ABCC2—digestive system—esophageal cancer	0.000102	0.00601	CbGeAlD
Cisplatin—Ulcer—Capecitabine—esophageal cancer	0.000101	0.00688	CcSEcCtD
Cisplatin—Dysarthria—Capecitabine—esophageal cancer	0.000101	0.00688	CcSEcCtD
Cisplatin—Hearing impaired—Capecitabine—esophageal cancer	9.99e-05	0.00684	CcSEcCtD
Cisplatin—BCHE—bronchus—esophageal cancer	9.94e-05	0.00587	CbGeAlD
Cisplatin—BCHE—smooth muscle tissue—esophageal cancer	9.73e-05	0.00574	CbGeAlD
Cisplatin—Hiccups—Capecitabine—esophageal cancer	9.51e-05	0.00651	CcSEcCtD
Cisplatin—Hepatotoxicity—Methotrexate—esophageal cancer	9.17e-05	0.00628	CcSEcCtD
Cisplatin—Skin exfoliation—Capecitabine—esophageal cancer	9.08e-05	0.00622	CcSEcCtD
Cisplatin—Fluid retention—Capecitabine—esophageal cancer	9.03e-05	0.00618	CcSEcCtD
Cisplatin—Necrosis—Methotrexate—esophageal cancer	9.02e-05	0.00617	CcSEcCtD
Cisplatin—Abscess—Methotrexate—esophageal cancer	8.95e-05	0.00613	CcSEcCtD
Cisplatin—Neuropathy—Capecitabine—esophageal cancer	8.93e-05	0.00611	CcSEcCtD
Cisplatin—BCHE—trachea—esophageal cancer	8.93e-05	0.00527	CbGeAlD
Cisplatin—CYP2B6—bronchus—esophageal cancer	8.86e-05	0.00523	CbGeAlD
Cisplatin—ABCC5—lymph node—esophageal cancer	8.66e-05	0.00512	CbGeAlD
Cisplatin—Extravasation—Methotrexate—esophageal cancer	8.12e-05	0.00555	CcSEcCtD
Cisplatin—NQO1—lymph node—esophageal cancer	8.11e-05	0.00479	CbGeAlD
Cisplatin—Phlebitis—Capecitabine—esophageal cancer	8.02e-05	0.00549	CcSEcCtD
Cisplatin—Polyuria—Capecitabine—esophageal cancer	7.87e-05	0.00538	CcSEcCtD
Cisplatin—PTGS2—epithelium—esophageal cancer	7.78e-05	0.00459	CbGeAlD
Cisplatin—Deafness—Capecitabine—esophageal cancer	7.72e-05	0.00528	CcSEcCtD
Cisplatin—BCHE—digestive system—esophageal cancer	7.68e-05	0.00453	CbGeAlD
Cisplatin—PTGS2—bronchus—esophageal cancer	7.66e-05	0.00452	CbGeAlD
Cisplatin—Haemolytic anaemia—Capecitabine—esophageal cancer	7.65e-05	0.00523	CcSEcCtD
Cisplatin—Hyperuricaemia—Methotrexate—esophageal cancer	7.63e-05	0.00522	CcSEcCtD
Cisplatin—PTGS2—smooth muscle tissue—esophageal cancer	7.49e-05	0.00442	CbGeAlD
Cisplatin—Dysarthria—Methotrexate—esophageal cancer	7.49e-05	0.00512	CcSEcCtD
Cisplatin—Ulcer—Methotrexate—esophageal cancer	7.49e-05	0.00512	CcSEcCtD
Cisplatin—Renal failure acute—Capecitabine—esophageal cancer	7.48e-05	0.00512	CcSEcCtD
Cisplatin—MPO—lymph node—esophageal cancer	7.45e-05	0.0044	CbGeAlD
Cisplatin—Amnesia—Capecitabine—esophageal cancer	7.35e-05	0.00503	CcSEcCtD
Cisplatin—ABCC3—lymph node—esophageal cancer	7.28e-05	0.0043	CbGeAlD
Cisplatin—GSTP1—lymph node—esophageal cancer	7.24e-05	0.00428	CbGeAlD
Cisplatin—Blood uric acid increased—Methotrexate—esophageal cancer	7.21e-05	0.00494	CcSEcCtD
Cisplatin—Cerebrovascular accident—Capecitabine—esophageal cancer	7.05e-05	0.00482	CcSEcCtD
Cisplatin—Hyponatraemia—Capecitabine—esophageal cancer	6.93e-05	0.00474	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	6.91e-05	0.00473	CcSEcCtD
Cisplatin—PTGS2—trachea—esophageal cancer	6.88e-05	0.00406	CbGeAlD
Cisplatin—CYP2B6—digestive system—esophageal cancer	6.85e-05	0.00404	CbGeAlD
Cisplatin—CYP2C9—digestive system—esophageal cancer	6.78e-05	0.004	CbGeAlD
Cisplatin—Skin exfoliation—Methotrexate—esophageal cancer	6.76e-05	0.00463	CcSEcCtD
Cisplatin—Face oedema—Capecitabine—esophageal cancer	6.67e-05	0.00456	CcSEcCtD
Cisplatin—Irritability—Capecitabine—esophageal cancer	6.59e-05	0.00451	CcSEcCtD
Cisplatin—Blood creatinine increased—Capecitabine—esophageal cancer	6.47e-05	0.00443	CcSEcCtD
Cisplatin—Dehydration—Capecitabine—esophageal cancer	6.42e-05	0.00439	CcSEcCtD
Cisplatin—BCHE—lung—esophageal cancer	6.41e-05	0.00379	CbGeAlD
Cisplatin—Orthostatic hypotension—Capecitabine—esophageal cancer	6.31e-05	0.00432	CcSEcCtD
Cisplatin—Hypokalaemia—Capecitabine—esophageal cancer	6.29e-05	0.0043	CcSEcCtD
Cisplatin—Breast disorder—Capecitabine—esophageal cancer	6.24e-05	0.00427	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	6.22e-05	0.00426	CcSEcCtD
Cisplatin—ABCG2—lung—esophageal cancer	6.2e-05	0.00366	CbGeAlD
Cisplatin—Nasopharyngitis—Capecitabine—esophageal cancer	6.18e-05	0.00423	CcSEcCtD
Cisplatin—PTGS2—digestive system—esophageal cancer	5.92e-05	0.00349	CbGeAlD
Cisplatin—Polyuria—Methotrexate—esophageal cancer	5.85e-05	0.00401	CcSEcCtD
Cisplatin—Sweating increased—Capecitabine—esophageal cancer	5.81e-05	0.00398	CcSEcCtD
Cisplatin—ABCC2—lymph node—esophageal cancer	5.81e-05	0.00343	CbGeAlD
Cisplatin—Abdominal discomfort—Capecitabine—esophageal cancer	5.72e-05	0.00392	CcSEcCtD
Cisplatin—CYP2B6—lung—esophageal cancer	5.72e-05	0.00338	CbGeAlD
Cisplatin—Pancytopenia—Capecitabine—esophageal cancer	5.67e-05	0.00388	CcSEcCtD
Cisplatin—Renal failure acute—Methotrexate—esophageal cancer	5.57e-05	0.00381	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Methotrexate—esophageal cancer	5.31e-05	0.00363	CcSEcCtD
Cisplatin—Acute coronary syndrome—Capecitabine—esophageal cancer	5.25e-05	0.00359	CcSEcCtD
Cisplatin—Cerebrovascular accident—Methotrexate—esophageal cancer	5.25e-05	0.00359	CcSEcCtD
Cisplatin—Renal failure—Capecitabine—esophageal cancer	5.23e-05	0.00358	CcSEcCtD
Cisplatin—Myocardial infarction—Capecitabine—esophageal cancer	5.22e-05	0.00357	CcSEcCtD
Cisplatin—Neuropathy peripheral—Capecitabine—esophageal cancer	5.22e-05	0.00357	CcSEcCtD
Cisplatin—Stomatitis—Capecitabine—esophageal cancer	5.19e-05	0.00355	CcSEcCtD
Cisplatin—Conjunctivitis—Capecitabine—esophageal cancer	5.17e-05	0.00354	CcSEcCtD
Cisplatin—Hepatobiliary disease—Capecitabine—esophageal cancer	5.03e-05	0.00344	CcSEcCtD
Cisplatin—PTGS2—lung—esophageal cancer	4.94e-05	0.00292	CbGeAlD
Cisplatin—Irritability—Methotrexate—esophageal cancer	4.91e-05	0.00336	CcSEcCtD
Cisplatin—Bradycardia—Capecitabine—esophageal cancer	4.86e-05	0.00333	CcSEcCtD
Cisplatin—ABCB1—epithelium—esophageal cancer	4.81e-05	0.00284	CbGeAlD
Cisplatin—Urinary tract disorder—Capecitabine—esophageal cancer	4.72e-05	0.00323	CcSEcCtD
Cisplatin—Connective tissue disorder—Capecitabine—esophageal cancer	4.69e-05	0.00321	CcSEcCtD
Cisplatin—Urethral disorder—Capecitabine—esophageal cancer	4.68e-05	0.0032	CcSEcCtD
Cisplatin—Breast disorder—Methotrexate—esophageal cancer	4.65e-05	0.00318	CcSEcCtD
Cisplatin—Visual impairment—Capecitabine—esophageal cancer	4.6e-05	0.00315	CcSEcCtD
Cisplatin—Eye disorder—Capecitabine—esophageal cancer	4.46e-05	0.00306	CcSEcCtD
Cisplatin—Tinnitus—Capecitabine—esophageal cancer	4.45e-05	0.00305	CcSEcCtD
Cisplatin—Cardiac disorder—Capecitabine—esophageal cancer	4.43e-05	0.00303	CcSEcCtD
Cisplatin—Flushing—Capecitabine—esophageal cancer	4.43e-05	0.00303	CcSEcCtD
Cisplatin—BCHE—lymph node—esophageal cancer	4.39e-05	0.00259	CbGeAlD
Cisplatin—Pancreatitis—Methotrexate—esophageal cancer	4.36e-05	0.00298	CcSEcCtD
Cisplatin—Immune system disorder—Capecitabine—esophageal cancer	4.32e-05	0.00295	CcSEcCtD
Cisplatin—Mediastinal disorder—Capecitabine—esophageal cancer	4.31e-05	0.00295	CcSEcCtD
Cisplatin—Arrhythmia—Capecitabine—esophageal cancer	4.27e-05	0.00292	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—esophageal cancer	4.26e-05	0.00291	CcSEcCtD
Cisplatin—ABCB1—trachea—esophageal cancer	4.25e-05	0.00251	CbGeAlD
Cisplatin—ABCG2—lymph node—esophageal cancer	4.24e-05	0.0025	CbGeAlD
Cisplatin—Alopecia—Capecitabine—esophageal cancer	4.22e-05	0.00289	CcSEcCtD
Cisplatin—Pancytopenia—Methotrexate—esophageal cancer	4.22e-05	0.00289	CcSEcCtD
Cisplatin—Erythema—Capecitabine—esophageal cancer	4.16e-05	0.00285	CcSEcCtD
Cisplatin—Malnutrition—Capecitabine—esophageal cancer	4.16e-05	0.00285	CcSEcCtD
Cisplatin—Flatulence—Capecitabine—esophageal cancer	4.1e-05	0.0028	CcSEcCtD
Cisplatin—Muscle spasms—Capecitabine—esophageal cancer	4e-05	0.00274	CcSEcCtD
Cisplatin—Vision blurred—Capecitabine—esophageal cancer	3.92e-05	0.00268	CcSEcCtD
Cisplatin—Tremor—Capecitabine—esophageal cancer	3.9e-05	0.00267	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—esophageal cancer	3.89e-05	0.00267	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—esophageal cancer	3.86e-05	0.00264	CcSEcCtD
Cisplatin—Ill-defined disorder—Capecitabine—esophageal cancer	3.86e-05	0.00264	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—esophageal cancer	3.85e-05	0.00264	CcSEcCtD
Cisplatin—Anaemia—Capecitabine—esophageal cancer	3.84e-05	0.00263	CcSEcCtD
Cisplatin—Malaise—Capecitabine—esophageal cancer	3.75e-05	0.00257	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—esophageal cancer	3.75e-05	0.00256	CcSEcCtD
Cisplatin—Leukopenia—Capecitabine—esophageal cancer	3.72e-05	0.00255	CcSEcCtD
Cisplatin—ABCB1—digestive system—esophageal cancer	3.66e-05	0.00216	CbGeAlD
Cisplatin—Myalgia—Capecitabine—esophageal cancer	3.54e-05	0.00242	CcSEcCtD
Cisplatin—Anxiety—Capecitabine—esophageal cancer	3.53e-05	0.00241	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	3.52e-05	0.00241	CcSEcCtD
Cisplatin—Urinary tract disorder—Methotrexate—esophageal cancer	3.51e-05	0.0024	CcSEcCtD
Cisplatin—Discomfort—Capecitabine—esophageal cancer	3.5e-05	0.00239	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—esophageal cancer	3.49e-05	0.00239	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—esophageal cancer	3.43e-05	0.00235	CcSEcCtD
Cisplatin—Oedema—Capecitabine—esophageal cancer	3.39e-05	0.00232	CcSEcCtD
Cisplatin—PTGS2—lymph node—esophageal cancer	3.38e-05	0.002	CbGeAlD
Cisplatin—Infection—Capecitabine—esophageal cancer	3.37e-05	0.00231	CcSEcCtD
Cisplatin—Nervous system disorder—Capecitabine—esophageal cancer	3.33e-05	0.00228	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—esophageal cancer	3.32e-05	0.00227	CcSEcCtD
Cisplatin—Thrombocytopenia—Capecitabine—esophageal cancer	3.32e-05	0.00227	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—esophageal cancer	3.32e-05	0.00227	CcSEcCtD
Cisplatin—Tachycardia—Capecitabine—esophageal cancer	3.31e-05	0.00227	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—esophageal cancer	3.3e-05	0.00226	CcSEcCtD
Cisplatin—Skin disorder—Capecitabine—esophageal cancer	3.3e-05	0.00226	CcSEcCtD
Cisplatin—Hyperhidrosis—Capecitabine—esophageal cancer	3.28e-05	0.00225	CcSEcCtD
Cisplatin—Anorexia—Capecitabine—esophageal cancer	3.24e-05	0.00221	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—esophageal cancer	3.21e-05	0.0022	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—esophageal cancer	3.21e-05	0.00219	CcSEcCtD
Cisplatin—Hypotension—Capecitabine—esophageal cancer	3.17e-05	0.00217	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—esophageal cancer	3.14e-05	0.00215	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—esophageal cancer	3.1e-05	0.00212	CcSEcCtD
Cisplatin—Erythema—Methotrexate—esophageal cancer	3.1e-05	0.00212	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	3.09e-05	0.00212	CcSEcCtD
Cisplatin—ABCB1—lung—esophageal cancer	3.06e-05	0.0018	CbGeAlD
Cisplatin—Paraesthesia—Capecitabine—esophageal cancer	3.05e-05	0.00209	CcSEcCtD
Cisplatin—Dyspnoea—Capecitabine—esophageal cancer	3.03e-05	0.00207	CcSEcCtD
Cisplatin—Decreased appetite—Capecitabine—esophageal cancer	2.95e-05	0.00202	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Capecitabine—esophageal cancer	2.93e-05	0.00201	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—esophageal cancer	2.92e-05	0.002	CcSEcCtD
Cisplatin—Pain—Capecitabine—esophageal cancer	2.9e-05	0.00199	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—esophageal cancer	2.87e-05	0.00197	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—esophageal cancer	2.86e-05	0.00196	CcSEcCtD
Cisplatin—Feeling abnormal—Capecitabine—esophageal cancer	2.8e-05	0.00191	CcSEcCtD
Cisplatin—Malaise—Methotrexate—esophageal cancer	2.79e-05	0.00191	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—esophageal cancer	2.77e-05	0.0019	CcSEcCtD
Cisplatin—Body temperature increased—Capecitabine—esophageal cancer	2.68e-05	0.00184	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—esophageal cancer	2.68e-05	0.00184	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—esophageal cancer	2.64e-05	0.0018	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	2.62e-05	0.00179	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—esophageal cancer	2.6e-05	0.00178	CcSEcCtD
Cisplatin—Anaphylactic shock—Methotrexate—esophageal cancer	2.53e-05	0.00173	CcSEcCtD
Cisplatin—Infection—Methotrexate—esophageal cancer	2.51e-05	0.00172	CcSEcCtD
Cisplatin—Hypersensitivity—Capecitabine—esophageal cancer	2.5e-05	0.00171	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—esophageal cancer	2.48e-05	0.0017	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—esophageal cancer	2.47e-05	0.00169	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—esophageal cancer	2.45e-05	0.00168	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—esophageal cancer	2.44e-05	0.00167	CcSEcCtD
Cisplatin—Asthenia—Capecitabine—esophageal cancer	2.44e-05	0.00167	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—esophageal cancer	2.41e-05	0.00165	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—esophageal cancer	2.36e-05	0.00162	CcSEcCtD
Cisplatin—Diarrhoea—Capecitabine—esophageal cancer	2.32e-05	0.00159	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	2.3e-05	0.00158	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—esophageal cancer	2.27e-05	0.00155	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—esophageal cancer	2.25e-05	0.00154	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—esophageal cancer	2.2e-05	0.0015	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—esophageal cancer	2.18e-05	0.00149	CcSEcCtD
Cisplatin—Pain—Methotrexate—esophageal cancer	2.16e-05	0.00148	CcSEcCtD
Cisplatin—Vomiting—Capecitabine—esophageal cancer	2.16e-05	0.00148	CcSEcCtD
Cisplatin—Rash—Capecitabine—esophageal cancer	2.14e-05	0.00146	CcSEcCtD
Cisplatin—Dermatitis—Capecitabine—esophageal cancer	2.14e-05	0.00146	CcSEcCtD
Cisplatin—ABCB1—lymph node—esophageal cancer	2.09e-05	0.00123	CbGeAlD
Cisplatin—Feeling abnormal—Methotrexate—esophageal cancer	2.08e-05	0.00142	CcSEcCtD
Cisplatin—Nausea—Capecitabine—esophageal cancer	2.02e-05	0.00138	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—esophageal cancer	2e-05	0.00137	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—esophageal cancer	1.86e-05	0.00127	CcSEcCtD
Cisplatin—Asthenia—Methotrexate—esophageal cancer	1.81e-05	0.00124	CcSEcCtD
Cisplatin—Diarrhoea—Methotrexate—esophageal cancer	1.73e-05	0.00118	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—esophageal cancer	1.61e-05	0.0011	CcSEcCtD
Cisplatin—Rash—Methotrexate—esophageal cancer	1.59e-05	0.00109	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—esophageal cancer	1.59e-05	0.00109	CcSEcCtD
Cisplatin—Nausea—Methotrexate—esophageal cancer	1.5e-05	0.00103	CcSEcCtD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.81e-06	4.78e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.81e-06	4.78e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.8e-06	4.76e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP26A1—esophageal cancer	1.79e-06	4.74e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALDH2—esophageal cancer	1.78e-06	4.71e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TYMP—esophageal cancer	1.77e-06	4.68e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.77e-06	4.68e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.77e-06	4.68e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALDH2—esophageal cancer	1.76e-06	4.66e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ENO1—esophageal cancer	1.76e-06	4.65e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS1—esophageal cancer	1.76e-06	4.65e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALOX15—esophageal cancer	1.75e-06	4.62e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CREBBP—esophageal cancer	1.74e-06	4.61e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CREBBP—esophageal cancer	1.74e-06	4.61e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PSME1—esophageal cancer	1.73e-06	4.58e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PSME2—esophageal cancer	1.73e-06	4.58e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP26A1—esophageal cancer	1.72e-06	4.55e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.71e-06	4.53e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CA1—esophageal cancer	1.71e-06	4.53e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CREBBP—esophageal cancer	1.7e-06	4.49e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTT1—esophageal cancer	1.69e-06	4.48e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—esophageal cancer	1.68e-06	4.44e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—HMOX1—esophageal cancer	1.68e-06	4.44e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALOX15—esophageal cancer	1.68e-06	4.44e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTT1—esophageal cancer	1.68e-06	4.43e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CA2—esophageal cancer	1.68e-06	4.43e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP2A6—esophageal cancer	1.67e-06	4.43e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTO1—esophageal cancer	1.66e-06	4.41e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TPI1—esophageal cancer	1.66e-06	4.41e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP2A6—esophageal cancer	1.66e-06	4.38e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.65e-06	4.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—XIAP—esophageal cancer	1.62e-06	4.29e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ABCB1—esophageal cancer	1.61e-06	4.26e-05	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PIK3CA—esophageal cancer	1.6e-06	4.24e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TPI1—esophageal cancer	1.6e-06	4.23e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTO1—esophageal cancer	1.6e-06	4.23e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.6e-06	4.23e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALDOB—esophageal cancer	1.6e-06	4.22e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ENO1—esophageal cancer	1.59e-06	4.2e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS1—esophageal cancer	1.59e-06	4.2e-05	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.58e-06	4.19e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS1—esophageal cancer	1.57e-06	4.15e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ENO1—esophageal cancer	1.57e-06	4.15e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.57e-06	4.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CA2—esophageal cancer	1.56e-06	4.14e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PSME2—esophageal cancer	1.56e-06	4.14e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PSME1—esophageal cancer	1.56e-06	4.14e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NOS3—esophageal cancer	1.56e-06	4.13e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—NOS3—esophageal cancer	1.56e-06	4.13e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLCE1—esophageal cancer	1.56e-06	4.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ADH7—esophageal cancer	1.56e-06	4.12e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PSME2—esophageal cancer	1.55e-06	4.09e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PSME1—esophageal cancer	1.55e-06	4.09e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.54e-06	4.09e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GAPDH—esophageal cancer	1.54e-06	4.07e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALDOB—esophageal cancer	1.53e-06	4.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.53e-06	4.06e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.53e-06	4.05e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CREBBP—esophageal cancer	1.52e-06	4.03e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CRABP1—esophageal cancer	1.52e-06	4.03e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—NOS3—esophageal cancer	1.52e-06	4.02e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.51e-06	4e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—B2M—esophageal cancer	1.51e-06	3.99e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP1B1—esophageal cancer	1.49e-06	3.95e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.48e-06	3.93e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GAPDH—esophageal cancer	1.48e-06	3.91e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.47e-06	3.89e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CRABP1—esophageal cancer	1.46e-06	3.87e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CREBBP—esophageal cancer	1.46e-06	3.86e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—esophageal cancer	1.46e-06	3.86e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ADH7—esophageal cancer	1.45e-06	3.85e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.45e-06	3.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNG7—esophageal cancer	1.45e-06	3.83e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ENO1—esophageal cancer	1.44e-06	3.82e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.44e-06	3.81e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.43e-06	3.79e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—esophageal cancer	1.43e-06	3.78e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—esophageal cancer	1.43e-06	3.78e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PSME2—esophageal cancer	1.42e-06	3.77e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PSME1—esophageal cancer	1.42e-06	3.77e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP19A1—esophageal cancer	1.41e-06	3.72e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—EP300—esophageal cancer	1.4e-06	3.69e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNG7—esophageal cancer	1.39e-06	3.68e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—esophageal cancer	1.39e-06	3.68e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CALR—esophageal cancer	1.37e-06	3.61e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ADH1B—esophageal cancer	1.37e-06	3.61e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—NOS3—esophageal cancer	1.36e-06	3.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALDH2—esophageal cancer	1.36e-06	3.59e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1B1—esophageal cancer	1.35e-06	3.57e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.34e-06	3.53e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1B1—esophageal cancer	1.33e-06	3.53e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FBXW7—esophageal cancer	1.32e-06	3.5e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—NOS3—esophageal cancer	1.31e-06	3.46e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TYMP—esophageal cancer	1.31e-06	3.45e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALDH2—esophageal cancer	1.3e-06	3.45e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTT1—esophageal cancer	1.29e-06	3.42e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—HMOX1—esophageal cancer	1.28e-06	3.39e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.28e-06	3.39e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP2A6—esophageal cancer	1.28e-06	3.38e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.28e-06	3.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.27e-06	3.36e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.27e-06	3.36e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP19A1—esophageal cancer	1.27e-06	3.36e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CREBBP—esophageal cancer	1.27e-06	3.35e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.26e-06	3.33e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP19A1—esophageal cancer	1.25e-06	3.32e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.25e-06	3.31e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1A—esophageal cancer	1.25e-06	3.3e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—esophageal cancer	1.25e-06	3.3e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.24e-06	3.28e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALOX15—esophageal cancer	1.24e-06	3.27e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ABCB1—esophageal cancer	1.23e-06	3.26e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.23e-06	3.25e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TYMP—esophageal cancer	1.22e-06	3.23e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.22e-06	3.22e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ENO1—esophageal cancer	1.21e-06	3.2e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTGS1—esophageal cancer	1.21e-06	3.2e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—esophageal cancer	1.2e-06	3.16e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PSME1—esophageal cancer	1.19e-06	3.15e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PSME2—esophageal cancer	1.19e-06	3.15e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EP300—esophageal cancer	1.19e-06	3.14e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—EP300—esophageal cancer	1.19e-06	3.14e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.19e-06	3.14e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TPI1—esophageal cancer	1.18e-06	3.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTO1—esophageal cancer	1.18e-06	3.12e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ENO1—esophageal cancer	1.16e-06	3.08e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.16e-06	3.08e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HMOX1—esophageal cancer	1.16e-06	3.06e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—EP300—esophageal cancer	1.16e-06	3.06e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.16e-06	3.06e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PSME2—esophageal cancer	1.15e-06	3.03e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PSME1—esophageal cancer	1.15e-06	3.03e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HMOX1—esophageal cancer	1.15e-06	3.03e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—NOS3—esophageal cancer	1.13e-06	3e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALDOB—esophageal cancer	1.13e-06	2.99e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ABCB1—esophageal cancer	1.11e-06	2.94e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.1e-06	2.92e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TPI1—esophageal cancer	1.1e-06	2.92e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ABCB1—esophageal cancer	1.1e-06	2.91e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GAPDH—esophageal cancer	1.09e-06	2.88e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.09e-06	2.88e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CRABP1—esophageal cancer	1.08e-06	2.86e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CREBBP—esophageal cancer	1.08e-06	2.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFBR2—esophageal cancer	1.07e-06	2.83e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.06e-06	2.8e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.05e-06	2.78e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—EP300—esophageal cancer	1.04e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—esophageal cancer	1.04e-06	2.74e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—esophageal cancer	1.03e-06	2.74e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—esophageal cancer	1.03e-06	2.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.03e-06	2.72e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNG7—esophageal cancer	1.03e-06	2.72e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.02e-06	2.69e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—esophageal cancer	1.01e-06	2.68e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SMAD4—esophageal cancer	1.01e-06	2.68e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.01e-06	2.67e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—EP300—esophageal cancer	9.95e-07	2.63e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1B1—esophageal cancer	9.89e-07	2.62e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP19A1—esophageal cancer	9.67e-07	2.56e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NOS3—esophageal cancer	9.64e-07	2.55e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALDH2—esophageal cancer	9.62e-07	2.55e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNG7—esophageal cancer	9.59e-07	2.54e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.3e-07	2.46e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP19A1—esophageal cancer	9.29e-07	2.46e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTT1—esophageal cancer	9.15e-07	2.42e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2A6—esophageal cancer	9.05e-07	2.39e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.99e-07	2.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HMOX1—esophageal cancer	8.83e-07	2.34e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—esophageal cancer	8.82e-07	2.33e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—esophageal cancer	8.78e-07	2.32e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—esophageal cancer	8.78e-07	2.32e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.66e-07	2.29e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—EP300—esophageal cancer	8.62e-07	2.28e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO1—esophageal cancer	8.58e-07	2.27e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS1—esophageal cancer	8.58e-07	2.27e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.57e-07	2.27e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—esophageal cancer	8.56e-07	2.26e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTT1—esophageal cancer	8.55e-07	2.26e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HMOX1—esophageal cancer	8.48e-07	2.24e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCB1—esophageal cancer	8.47e-07	2.24e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2A6—esophageal cancer	8.45e-07	2.24e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PSME2—esophageal cancer	8.45e-07	2.24e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PSME1—esophageal cancer	8.45e-07	2.24e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.42e-07	2.23e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HIF1A—esophageal cancer	8.28e-07	2.19e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CREBBP—esophageal cancer	8.22e-07	2.18e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCB1—esophageal cancer	8.14e-07	2.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO1—esophageal cancer	8.01e-07	2.12e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS1—esophageal cancer	8.01e-07	2.12e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PSME1—esophageal cancer	7.89e-07	2.09e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PSME2—esophageal cancer	7.89e-07	2.09e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—esophageal cancer	7.67e-07	2.03e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS2—esophageal cancer	7.53e-07	1.99e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOTCH1—esophageal cancer	7.46e-07	1.97e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CREBBP—esophageal cancer	7.42e-07	1.96e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NOS3—esophageal cancer	7.36e-07	1.95e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—esophageal cancer	7.36e-07	1.95e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CREBBP—esophageal cancer	7.35e-07	1.94e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—EP300—esophageal cancer	7.33e-07	1.94e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1B1—esophageal cancer	7.29e-07	1.93e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.89e-07	1.82e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP19A1—esophageal cancer	6.86e-07	1.81e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.81e-07	1.8e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CREBBP—esophageal cancer	6.76e-07	1.79e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—esophageal cancer	6.74e-07	1.78e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NOS3—esophageal cancer	6.65e-07	1.76e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NOS3—esophageal cancer	6.58e-07	1.74e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.4e-07	1.69e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.4e-07	1.69e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—esophageal cancer	6.38e-07	1.69e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HMOX1—esophageal cancer	6.26e-07	1.66e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—esophageal cancer	6.08e-07	1.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS3—esophageal cancer	6.05e-07	1.6e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—esophageal cancer	6.02e-07	1.59e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.84e-07	1.55e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.73e-07	1.52e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CREBBP—esophageal cancer	5.66e-07	1.5e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—esophageal cancer	5.66e-07	1.5e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.61e-07	1.48e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—EP300—esophageal cancer	5.6e-07	1.48e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CREBBP—esophageal cancer	5.44e-07	1.44e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—esophageal cancer	5.42e-07	1.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NOS3—esophageal cancer	5.07e-07	1.34e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—EP300—esophageal cancer	5.06e-07	1.34e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—EP300—esophageal cancer	5e-07	1.32e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NOS3—esophageal cancer	4.87e-07	1.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—esophageal cancer	4.84e-07	1.28e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EP300—esophageal cancer	4.6e-07	1.22e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—esophageal cancer	4.46e-07	1.18e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.24e-07	1.12e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—esophageal cancer	4.14e-07	1.1e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CREBBP—esophageal cancer	4.01e-07	1.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—esophageal cancer	4.01e-07	1.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—esophageal cancer	3.92e-07	1.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—EP300—esophageal cancer	3.86e-07	1.02e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.75e-07	9.92e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—esophageal cancer	3.74e-07	9.9e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—EP300—esophageal cancer	3.71e-07	9.81e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—esophageal cancer	3.7e-07	9.79e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NOS3—esophageal cancer	3.59e-07	9.51e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—esophageal cancer	3.41e-07	9.01e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NOS3—esophageal cancer	3.36e-07	8.88e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—esophageal cancer	3.29e-07	8.7e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.07e-07	8.12e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—esophageal cancer	2.85e-07	7.55e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.74e-07	7.25e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—EP300—esophageal cancer	2.73e-07	7.23e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—EP300—esophageal cancer	2.55e-07	6.76e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.02e-07	5.35e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.89e-07	5e-06	CbGpPWpGaD
